SPONSOR
Institut du Cancer de Montpellier - Val d'Aurelle
Total Trials
3
Recruiting
3
Phases
Phase 2
Conditions studied: Locally Advanced Pancreatic AdenocarcinomaCarcinoma, Ovarian EpithelialFallopian Tube NeoplasmsPeritoneal NeoplasmsNervous System Tumor
Institut du Cancer de Montpellier - Val d'Aurelle is a clinical research sponsor with 3 registered studies on ClinicalTrials.gov, of which 3 are actively recruiting participants. Research covers conditions including Locally Advanced Pancreatic Adenocarcinoma, Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Peritoneal Neoplasms.
The trial portfolio spans Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Institut du Cancer de Montpellier - Val d'Aurelle
How many clinical trials has Institut du Cancer de Montpellier - Val d'Aurelle sponsored?
ClinicalMetric currently tracks 3 clinical trials sponsored by Institut du Cancer de Montpellier - Val d'Aurelle, of which 3 are actively recruiting participants. These trials cover conditions including Locally Advanced Pancreatic Adenocarcinoma, Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Institut du Cancer de Montpellier - Val d'Aurelle research focus on?
Institut du Cancer de Montpellier - Val d'Aurelle clinical trials span Locally Advanced Pancreatic Adenocarcinoma, Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Peritoneal Neoplasms, Nervous System Tumor. The research pipeline includes Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Institut du Cancer de Montpellier - Val d'Aurelle clinical trial?
To participate in a Institut du Cancer de Montpellier - Val d'Aurelle trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Institut du Cancer de Montpellier - Val d'Aurelle trials with current recruitment status updated daily.
Clinical Trials by Institut du Cancer de Montpellier - Val d'Aurelle
NCT04570943 Phase 2
Recruiting
Sequential Treatment With GEMBRAX and Then FOLFIRINOX Followed by Stereotactic MRI-guided Radiotherapy in Patients With Locally Advanced Pancreatic Cancer
Locally Advanced Pancreatic Adenocarcinoma
NCT03976999
Recruiting
Development of a Cinical and Biological Database in Ovarian, Fallopian Tube and Peritoneal Cancers
Carcinoma, Ovarian Epithelial
NCT04516720
Recruiting
Creation of a Clinical Database on Primary Nervous System Tumors
Nervous System Tumor
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology